< Back to situation

[REVISION HISTORY]

ADHD mortality risk and medication safety research

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-24 12:19 UTC → 2026-10-27 11:04 UTC · added removed

ADHD and premature mortality and cognitive risk and medication safety research

A large-scale meta-analysis involving approximately 16 million people across 19 observational studies has identified a significant link between attention-deficit/hyperactivity disorder (ADHD) and increased mortality risk. Research indicates that individuals with ADHD face a 70% to 71% higher risk of premature death compared to those without the condition. The elevated risk is driven by several factors: suicide-related deaths showed the highest increase, with reports ranging from 89% to 90% higher risk. Deaths from external causes, such as accidental injuries and trauma, were approximately 55% higher, while deaths from natural causes were 27% more likely. Researchers suggest these risks may stem from impulse control difficulties, challenges with executive function, and difficulties managing chronic health conditions. Additionally, adults with ADHD are nearly three times more likely to experience depression and face higher rates of societal stigma. Specific demographic findings noted that women with ADHD could face a reduction in life expectancy of up to 11 years, while men could face a reduction of up to nine years. However, the analysis suggests that pharmacological treatment may offer protective benefits, with medicated individuals showing a 25% lower risk of death from any cause compared to those not receiving medication. Further research published in JAMA Psychiatry has identified a connection between ADHD and an increased risk of developing mild cognitive impairment or dementia in later life. An analysis of approximately 187,000 adults aged 50 and older found that 6.7% of participants with ADHD were later diagnosed with these conditions, compared to 3.4% of those without ADHD. Researchers emphasized that this does not prove ADHD causes dementia. A recent international study has provided new insights into the safety of ADHD medications.

Versions

  1. 2026-10-27 11:04 UTC ADHD mortality risk and medication safety research
  2. 2026-10-24 12:19 UTC ADHD and premature mortality and cognitive risk research
  3. 2026-10-22 20:37 UTC ADHD and premature mortality risk research

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.